SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-071466
Filing Date
2023-03-15
Accepted
2023-03-15 17:15:58
Documents
11
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 S-3ASR d425477ds3asr.htm S-3ASR 403902
2 EX-1.2 d425477dex12.htm EX-1.2 212781
3 EX-4.4 d425477dex44.htm EX-4.4 32838
4 EX-4.5 d425477dex45.htm EX-4.5 265419
5 EX-5.1 d425477dex51.htm EX-5.1 34129
6 EX-23.1 d425477dex231.htm EX-23.1 1689
7 EX-FILING FEES d425477dexfilingfees.htm EX-FILING FEES 37772
8 GRAPHIC g425477g0310072937172.jpg GRAPHIC 3993
9 GRAPHIC g425477g09y62.jpg GRAPHIC 36137
10 GRAPHIC g425477g49o10.jpg GRAPHIC 37908
11 GRAPHIC g425477g68b17.jpg GRAPHIC 35211
  Complete submission text file 0001193125-23-071466.txt   1133266
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-270581 | Film No.: 23736156
SIC: 2834 Pharmaceutical Preparations